Xilio Therapeutics, Inc.XLONASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
23.77%
↑ 161% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthAccelerating
Average
-39.25%
Historical baseline
PeriodValue
202423.77%
202313.40%
2022-16.39%
2021-37.27%
2020-218.98%
20190.00%